Health Condition 1: G00-G99- Diseases of the nervous system
Conditions
Interventions
Intervention1: Habb e Mujarrab: Orally 3 tablets (250 mg each) BID with water after food
Intervention2: Habb Mujarrab: Orally 3 tablets (250 mg each) BID with water after food
for 60 days
Control Inte
Sponsors
National Institute of Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: 1. Diagnosed cases of Migraine without Aura (as per the International Classification of Headache Disorders (ICHD-3) with history for at least one year 2.Patients between the age of 18â??50 years 3.Patients of any gender 4. Patients who will give consent and are able to do follow up
Exclusion criteria
Exclusion criteria: 1.Headache other than Migraine without Aura 2.Use of any migraine prophylactic agents (b-blockers, anti-depressants, calcium channel blockers, anti-epileptic agents, cycle-modulating hormonal drugs, or vessel dilatation agents) within 1 month prior to screen 3.History or evidence of psychiatric disorder 4.Patients with a score of 19 or higher on the Beck Depression Inventory-II (BDI-II) 5.History of any systemic illness 6.Pregnant and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 50% Reduction in Monthly Migraine Days (MMD) Timepoint: 0th, 30th and 60th day | — |
Secondary
| Measure | Time frame |
|---|---|
| o Reduction in the Headache Impact Test (HIT-6) o Increase in the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQv2.1) Timepoint: 0th, 30th and 60th day | — |
Countries
India
Contacts
Public ContactDr Shahul Hameed Fathima Riswana
National Institute of Unani Medicine
Outcome results
None listed